• Login
  • About Alexion
    • Our Leadership
    • Our Partnerships
    • Our Ethical Standards
    • Our History
  • Patient Focus
    • Advocacy
    • Patient Stories
  • Products
    • Soliris®
      • PNH
      • aHUS
    • Strensiq®
    • Kanuma®
  • Research & Development
    • Our Pipeline
    • Development Programs
    • Investigator-Sponsored Research
    • Discovery Partnerships
  • Responsibility
    • Global Access to Medicines Policy
    • Main Menu
  • Careers
    • Job Opportunities
    • Why Choose Alexion
      • Culture
      • Compensation & Benefits
        • Work/Life Balance
        • Health & Wellness
        • Financial Security
        • Recognition & Rewards
        • Personal Growth & Development
      • Professional Development
  • Select a Country
    • North America
      • Canada
      • USA
    • Latin America
      • Argentina
      • Brazil
      • Colombia
      • Mexico
    • Europe, the Middle East & Africa
      • Alexion Europe
      • Belgium
      • Denmark
      • France
      • Germany
      • Ireland
      • Italy
      • Netherlands
      • Norway
      • Russia
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • UAE
      • UK
    • Asia Pacific
      • Australia
      • China
      • India
      • Japan
  • Investors
  • News
  • Contact
 
  • Select a Country
  • Investors
  • News
  • Contact

North America

  • Canada
  • United States

Latin America

  • Argentina
  • Brazil
  • Colombia
  • Mexico

Europe, the Middle East & Africa

  • Alexion Europe
  • Belgium
  • Denmark
  • France
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • UAE
  • United Kingdom

Asia Pacific

  • Australia
  • China
  • India
  • Japan
  • About Alexion
  • Patient Focus
  • Products
  • Research & Development
  • Responsibility
  • Careers
  • Select a Country
    • North America
      • Canada
      • USA
    • Latin America
      • Argentina
      • Brazil
      • Colombia
      • Mexico
    • Europe, the Middle East & Africa
      • Alexion Europe
      • Belgium
      • Denmark
      • France
      • Germany
      • Ireland
      • Italy
      • Netherlands
      • Norway
      • Russia
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • UAE
      • UK
    • Asia Pacific
      • Australia
      • China
      • India
      • Japan
  • Investors
  • News
  • Contact
  • Home
  • »
  • Newsroom
  • »
  • Press Releases

Press Releases

Press Releases

Filter by Category

  • All Press Releases
  • Company Releases
  • Company Statements
  • Financial Releases
  • Product Releases

Sort by Year

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
MediaInquiries MediaMaterials EmailAlerts

Press Releases

  • Alexion to Report Fourth Quarter and Full Year 2018 Results on Monday, February 4, 2019
    January 7, 2019
    HTML PDF
  • Alexion to Present at the 37th Annual J.P. Morgan Healthcare Conference
    January 2, 2019
    HTML PDF
  • Alexion to Present at the Goldman Sachs 11th Annual Healthcare CEO Conference
    December 21, 2018
    HTML PDF
  • Alexion Receives Early FDA Approval for ULTOMIRIS™ (Ravulizumab-cwvz) in Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
    December 21, 2018
    HTML PDF
  • Comprehensive Positive Phase 3 Data for Alexion’s ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria Presented at American Society of Hematology (ASH) Annual Meeting and Published in Blood
    December 3, 2018
    HTML PDF
  • Alexion to Present at the Evercore ISI Healthcare Conference
    November 20, 2018
    HTML PDF
  • Alexion to Present at Credit Suisse’s 27th Annual Healthcare Conference
    November 7, 2018
    HTML PDF
  • Alexion Completes Acquisition of Syntimmune
    November 2, 2018
    HTML PDF
  • Alexion Announces Upcoming Data Presentations at American Society of Hematology Annual Meeting
    November 1, 2018
    HTML PDF
  • Alexion Reports Third Quarter 2018 Results
    October 24, 2018
    HTML PDF
  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »
  • About Alexion
  • Patient Focus
  • Products
  • Research and Development
  • Responsibility
  • Careers

  • Investors
  • News
  • Contact
  • Site Map
  • Legal Statement
  • Global Privacy Program
  • Privacy Policy
  • Terms of Use
This website is intended only for residents of the United States.
© 2019 Alexion